Reduction of brain injury by antithrombotic agent acutobin after middle cerebral artery ischemia/reperfusion in the hyperglycemic rat

Brain Research

Volumn 1022, Issue 1-2, 2004, Pages 234-243

  Wei, Jing Na ^a   Wang, Qing Chuan ^b   Liu, Guang Fen ^b   Ezell, Edward L ^a   Quast, Michael J ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Acutobin; Cerebral ischemia; Defibrinogenating agent; Hyperglycemia; Magnetic resonance imaging; Thrombolitic

Indexed keywords

ACUTOBIN; ANTICOAGULANT AGENT; SNAKE VENOM; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DEINAGKISTRODON ACUTUS; DRUG EFFECT; HYPERGLYCEMIA; MALE; MEASUREMENT; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REPERFUSION; RIGHT HEMISPHERE; SNAKE; TISSUE PERFUSION;

ANIMALS; BRAIN INJURIES; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; CROTALID VENOMS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; HYPERGLYCEMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; REPERFUSION; THROMBIN; TIME FACTORS;

EID: 4444322520     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.07.019     Document Type: Article

References (67)

1. M. Andersen, K. Overgaard, P. Meden, and G. Boysen Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model Stroke 30 1999 1464 1471
2. L. Axel Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis Radiology 137 1980 679 686
3. J.B. Bederson, L.H. Pitts, S.M. Germano, M.C. Nishimura, R.L. Davis, and H.M. Bartkowski Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats Stroke 17 1986 1304 1308
4. L. Belayev, L. Khoutorova, T.A. Deisher, A. Belayev, R. Busto, Y. Zhang, W. Zhao, and M.D. Ginsberg Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transit middle cerebral occlusion in rats Stroke 34 2003 758 763
5. J.A. Caprini, H.C. Kwaan, L. Zuckerman, and R. Verduin Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution Thromb. Res. 4 1974 199 217
6. M.C. Chang, and T.F. Huang The antiplatelet activity of ancrod on administration to rabbits J. Lab. Clin. Med. 125 1995 508 516
7. B.M. Coull, P. de Garmo, G. Sexton, F. Nordt, R. Knox, and G.V. Seaman Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke Stroke 22 1991 162 168
8. S.H. David, and M.B. Bell Stroke in the diabetic patient Diabetes Care 17 1994 213 219
9. G.J. del Zoppo The role of platelets in ischemic stroke Neurology 51 1998 S9 S14
10. G.J. del Zoppo, G.W. Schmid-Schonbein, E. Mori, B.R. Copeland, and C.M. Chang Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons Stroke 22 1991 1276 1283
11. A.M. Demchuk, L.B. Morgenstern, D.W. Krieger, T.L. Chi, W. Hu, T.H. Wein, R.J. Hardy, J.C. Grotta, and A.M. Buchan Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke Stroke 30 1999 34 39
12. B. Elger, W. Hornberger, M. Schwarz, and J. Seega MRI study on delayed ancrod therapy of focal cerebral ischaemia in rats Eur. J. Pharmacol. 336 1997 7 14
13. M.P. Esnouf, and G.W. Tunnah The isolation and properties of the thrombin-like activity form ancistrodon rhodostoma venom Br. J. Pharmacol. 13 1967 581 590
14. M. Ewart, M. Hatton, and J. Basford The proteolytic action of Arvin on human fibrinogen Biochem. J. 117 1970 603 609
15. J. Frahm, A. Haase, and D. Matthaei Rapid NMR imaging of dynamic processes using the FLASH technique Magn. Reson. Med. 3 1986 321 327
16. M.W. Hatton, B. Ross, S.M. Southward, M. DeReske, and M. Richardson Pretreatment of rabbits with either hirudin, ancrod, or warfarin significantly reduces the immediate uptake of fibrinogen and platelets by the deendothelialized aorta wall after balloon catheter injury in vivo Arteriosler. Thromb. Vasc. Biol. 18 1998 816 824
17. W.H. Holleman, and L.J. Coen Characterization of peptides released from human fibrinogen by Arvin Biochem. Biophys. Acta 200 1970 587 589
18. N.C. Huang, J. Wei, and M.J. Quast A comparison of the early development of ischemic brain damage in normoglycemic and hyperglycemic rats using magnetic resonance imaging Exp. Brain Res. 109 1996 33 42
19. K.A. Illig, and K. Ouriel Ancrod: understanding the agent Semin. Vasc. Surg. 9 1996 303 314
20. 2 reactivity during hypocapnia in normal subjects Stroke 27 1996 1328 1332
21. N. Kawai, R.F. Keep, and A.L. Betz Hyperglycemia and the vascular effects of cerebral ischemia Stroke 28 1997 149 154
22. T.A. Kent, M.J. Quast, B.J. Kaplan, A. Najafi, E.G. Amparo, R.M. Gevedon, F. Salinas, A.D. Suttle, D.J. Dipette, and H.M. Eisenberg Cerebral blood volume in a rat model of ischemia by MR imaging at 4.7T Am. J. Neuroradiol. 10 1989 335 338
23. T.A. Kent, M.J. Quast, B.J. Kaplan, R.S. Lifsey, and H.M. Eisenberg Assessment of a superparamagnetic iron oxide (AMI-25) as a brain contrast agent Magn. Reson. Med. 13 1990 434 443
24. E. Kilic, D.M. Hermann, and K.A. Hossmann Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice NeuroReport 10 1999 107 111
25. R.A. Knight, R.J. Ordidge, J.A. Helpern, M. Chopp, L.C. Rodolosi, and D. Peck Temporal evolution of ischemic damage in rat brain measured by proton nuclear magnetic resonance imaging Stroke 22 1991 802 808
26. D. LeBihan, E. Breton, M. Lallem, P. Grenier, E. Cabanis, and M. Laval-Jeantet MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders Radiology 161 1986 401 407
27. A. Li, P.L. Gisselsson, J. Keuker, J. Vogel, M.L. Smith, W. Kuschinsky, and B.K. Siesjo Hyperglycemia-exaggerated ischemic brain damage following 30 min of middle cerebral artery occlusion is not due to capillary obstruction Brain Res. 804 1998 36 44
28. G. Liu, Q. Wang, Q. Chen, B. Liu, and L. Xue Chronic toxicity and pharmacological effects of thrombin-like enzymes purified form Deinakistrodon acutus venom after consecutive administration Fujian Med. Coll. 21 1987 270 274
29. G.F. Liu, Q.C. Wang, Q.C. Chen, and B.X. Liu Biochemical and pharmacological studies on thrombin-like enzymes of Agkistrodon acutua venom J. Fujian Med. Coll. 23 1989 303 309
30. G. Liu, Q. Wang, Q. Chen, and B. Liu Biochemical and pharmacological studies on thrombin-like enzymes of Agkistrodon acutus venom Fujian Med. Coll. 23 1989 303 309
31. G. Liu, J. Chen, Y. Qi, Q. Wang, X. Zhong, and P. Liang Effects of acutobin on the ultrastructure of rabbit and rat platelet J. Snake 12 2000 59 60
32. E.Z. Longa, P.R. Weinstein, S. Carlson, and R. Cummins Reversible middle cerebral artery occlusion without craniotomy in rats Stroke 20 1989 84 91
33. F.S. Markland Jr. Snake venoms Drugs 54 1997 1 10 (Suppl.)
34. D.C. Morris, L. Zhang, Z.G. Zhang, M. Lu, K.L. Berens, P.M. Brown, and M. Chopp Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke Stroke 32 2001 2635 2640
35. M.E. Moseley, Y. Cohen, J. Mintorovitch, L. Chileuitt, H. Shimizu, K. Kucharczyk, M.F. Wendland, and P.R. Weinstein Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy Magn. Reson. Med. 14 1990 330 346
36. 2 weighted and magnetic susceptibility-enhanced MR imaging in cats, AJNR Am. J. Neuroradiol. 11 1990 423 429
37. 1H MRI and intravascular contrast agent study Magn. Reson. Med. 23 1992 21 30
38. H. Nagasawa, and K. Kogure Correlation between cerebral blood flow and histological changes in a new rat model of middle cerebral artery occlusion Stroke 20 1989 1037 1043
39. H. Nakai, Y. Yamamoto, M. Diksic, K. Worsley, and E. Takara Tripletracer autoradiography demonstrates effects of hyperglycemia on cerebral blood flow, pH and glucose utilization in cerebral ischemia on rats Stroke 19 1988 764 772
40. M. Nedergaard, and N.H. Diemer Focal ischemia of the rat brain, with special reference to the influence of plasma glucose concentration Acta Neuropathol. Berl. 73 1987 131 137
41. R.M. Palmer, S. Rehncrona, B. Soderfeldt, Y. Olsson, and H. Kalimo Brain lactic acidosis and ischemic cell damage: quantitative ultrastructural changes in capillaries of rat cerebral cortex Acta Neuropathol. 60 1983 232 240
42. S.M. Papadopoulos, W.F. Chandler, M.S. Salamat, E.J. Topol, and J.C. Sackellares Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke J. Neurosurg. 67 1987 394 398
43. C.S. Patlak, and K.D. Pettigrew A method to obtain infusion schedules for prescribed blood concentration time courses Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 40 1976 458 463
44. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press New York
45. V.E. Pollak, P. Glas-Greenwalt, C.P. Olinger, N.K. Wadhwa, and S.A. Myre Ancrod causes rapid thrombolysis in patients with acute stroke Am. J. Med. Sci. 57 1990 319 325
46. M.J. Quast, N.C. Huang, G.R. Hillman, and T.A. Kent The evolution of acute stroke recorded by multimodal magnetic resonance imaging Magn. Reson. Imaging 11 1993 465 471
47. M.J. Quast, S.S. Klinke, and N.C. Huang In vivo relaxivities of ultrasmall superparamagnetic iron oxide in brain tissue Proc. Int. Soc. Magn. Reson. Med. 2 1994 8
48. G-nitro-l-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats Brain Res. 677 1995 204 212
49. M.J. Quast, J. Wei, N.C. Huang, D.G. Brunder, S.L. Sell, J.M. Gonzales, G.R. Hillman, and T.A. Kent Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats J. Cereb. Blood Flow Metab. 17 1997 553 559
50. D.G. Sherman, R.P. Atkinson, T. Chippendale, K.A. Levin, K. Ng, N. Futrell, Y. Chung, and D.E. Levy Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial JAMA 283 2000 2395 2403
51. M. Siebler, A. Nachtmann, M. Sitzer, and H. Steinmetz Anticoagulation monitoring and cerebral microemboli detection Life Sci. 344 1994 555
52. B.K. Siesjo, A. Ekholm, K. Katsura, and S. Theander Acid-base change during complete brain ischemia Stroke 21 1990 194 199
53. B.K. Siesjo, K. Katsura, P. Mellergard, A. Ekholm, J. Lundgren, and M. Smith Acidosis-related brain damage Prog. Brain Res. 96 1993 23 48
54. The Ancrod Stroke study investigators Ancrod for the treatment of acute ischemic brain infarction Stroke 25 1994 1775 1779
55. H.B. Verheul, R. Balazs, J.W. Berkelbach van der Sprenkel, C.A. Tulleken, K. Nicolay, K.S. Tamminga, and M. Van lookeren Campagne Comparison of diffusion-weighted MRI with changes in cell volume in a rat model of brain injury NMR Biomed. 7 1994 96 100
56. A. Villringer, B.R. Rosen, J.W. Belliveau, J.L. Ackerman, R.B. Lauffer, R.B. Buxton, Y.S. Chao, V.J. Wedeen, and T.J. Brady Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects Magn. Reson. Med. 6 1988 164 174
57. Q. Wang, Y. Xu, and G. Liu A preliminary analysis of the antithrombotic mechanism Agkistrodon acutus enzyme J. Snake 9 1997 9 11
58. J. Wei, and M.J. Quast Effect of nitric oxide synthase inhibitor on a hyperglycemic rat model of reversible focal ischemia: detection of excitatory amino acids release and hydroxyl radical formation Brain Res. 791 1998 146 156
59. J. Wei, N.C. Huang, and M.J. Quast Hydroxyl radical formation in hyperglycemic rats during middle cerebral artery occlusion/reperfusion Free Radic. Biol. Med. 23 1997 986 995
60. J. Wei, D.M. Cohen, and M.J. Quast Effects of 2-deoxy-d-glucose on focal cerebral ischemia in hyperglycemic rats J. Cereb. Blood Flow Metab. 23 2003 556 564
61. R.B. William Defibrinogenating enzymes Drugs 54 1997 18 30 (Suppl.)
62. M.A. Yenari, A. de Crespigny, J.T. Palmer, S. Roberts, S.L. Schrier, G.W. Albers, M.E. Moseley, and G.K. Steinberg Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke J. Cereb. Blood Flow Metab. 17 1997 401 411
63. P.K. Yip, Y.Y. He, C.Y. Hsu, N. Garg, P. Marangos, and E.L. Hogan Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion Neurology 41 1991 899 905
64. Z.G. Zhang, M. Chopp, A. Goussev, D. Lu, D. Morris, W. Tsang, C. Powers, and K.L. Ho Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats J. Neurosci. 19 1999 10898 10909
65. P. Zhao Clinical study on the efficacy of acutobin injection in treatment of 140 patients with acute cerebral infarction Chin. New Drugs J. 9 2000 267 268
66. Y. Zhao, G. Zhao, and Q. Chen Evaluation of acutobin injection in the treatment of acute cerebral infarction Chin. New Drugs J. 9 2000 266 267
67. K.L. Zierler Theoretical basis of indicator-dilution methods for measuring flow and volume Circ. Res. 10 1962 393 407